Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
Clinical Trials Summit 2026
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
Clinical Trials Summit 2026
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
Clinical Trials Summit 2026
Search here...
Search
Dose Daily News Bureau
facebook
instagram
linkedin
Exclusive Content
India Moves Toward Affordable Semaglutide with Dr. Reddy’s Laboratories Approval
Breaking News
Dose Daily News Bureau
-
April 16, 2026
India Tightens Oversight as Drugs Controller General of India Targets GLP-1 Misuse
Dose daily
Dose Daily News Bureau
-
April 14, 2026
Viksit Bharat Shiksha Bill Sparks Debate: What It Means for India’s Scientific and Pharma Ecosystem
Dose daily
Dose Daily News Bureau
-
April 13, 2026
Chicago Jury Orders Abbott Laboratories to Pay $70 Million in Premature Infant Formula Case
Dose daily
Dose Daily News Bureau
-
April 12, 2026
Sun Pharma’s $12B Organon Bid Signals India’s Boldest Global Pharma Expansion
Dose daily
Dose Daily News Bureau
-
April 11, 2026
Beyond Generics: Lupin Limited’s Dapagliflozin Approval Highlights Strategic Depth in Chronic Care
Dose daily
Dose Daily News Bureau
-
April 10, 2026
1
...
42
43
44
...
64
Page 43 of 64
I want in
I've read and accept the
Privacy Policy
.
Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown
admin
-
July 28, 2026
From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story
Breaking News
Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP
Breaking News
Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III
Breaking News
VELMENI Secures FDA Nod for Advanced AI-Driven 3D Dental Imaging
Breaking News
Oriflame India Transfers Manufacturing Operations to Akums Subsidiary Pure & Cure
Breaking News
×